8-K
Current Report
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-22-018538
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading rare-20220909.htm…